Orthopediatrics Corp financial data

Symbol
KIDS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2850 Frontier Drive, Warsaw, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 486 % -24.8%
Quick Ratio 249 % +5.53%
Debt-to-equity 16.5 % +22.6%
Return On Equity -6.73 % -2651%
Return On Assets -5.78 % -2585%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.2M shares +3.7%
Common Stock, Shares, Outstanding 23.4M shares +2.19%
Entity Public Float 445M USD -5.6%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 23.1M shares +1.94%
Weighted Average Number of Shares Outstanding, Diluted 23.1M shares +1.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 175M USD +27.7%
Research and Development Expense 10.3M USD +6.97%
Selling and Marketing Expense 56.1M USD +14.6%
General and Administrative Expense 91.2M USD +34.3%
Operating Income (Loss) -28M USD +5.04%
Nonoperating Income (Expense) 935K USD -96.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -27M USD -549%
Income Tax Expense (Benefit) -1.91M USD +63%
Net Income (Loss) Attributable to Parent -25.1M USD -2614%
Earnings Per Share, Basic -1.09 USD/shares -1008%
Earnings Per Share, Diluted -1.09 USD/shares -1008%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.9M USD +198%
Accounts Receivable, after Allowance for Credit Loss, Current 42M USD +24.2%
Inventory, Net 116M USD +27.9%
Assets, Current 194M USD -13.2%
Property, Plant and Equipment, Net 53.5M USD +33.5%
Operating Lease, Right-of-Use Asset 4.54M USD +882%
Goodwill 90.5M USD +9.17%
Other Assets, Noncurrent 6.47M USD +953%
Assets 431M USD -0.95%
Accounts Payable, Current 17M USD -18.6%
Employee-related Liabilities, Current 12.6M USD +54.6%
Liabilities, Current 39.6M USD -10.7%
Deferred Income Tax Liabilities, Net 4.74M USD -14.8%
Other Liabilities, Noncurrent 3.01M USD +435%
Liabilities 59.5M USD +9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.2M USD -29.2%
Retained Earnings (Accumulated Deficit) -212M USD -13.5%
Stockholders' Equity Attributable to Parent 371M USD -2.37%
Liabilities and Equity 431M USD -0.95%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.69M USD -3.54%
Net Cash Provided by (Used in) Financing Activities -573K USD -1492%
Net Cash Provided by (Used in) Investing Activities -3.68M USD -111%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 24.2M shares +3.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.46M USD -137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.9M USD +173%
Interest Paid, Excluding Capitalized Interest, Operating Activities 223K USD +1927%
Deferred Tax Assets, Valuation Allowance 41.9M USD +14%
Deferred Tax Assets, Gross 52.8M USD +9.33%
Operating Lease, Liability 4.16M USD +875%
Payments to Acquire Property, Plant, and Equipment 6.46M USD +30.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -27.4M USD -750%
Property, Plant and Equipment, Gross 80.6M USD +23.9%
Deferred Income Tax Expense (Benefit) -2.45M USD -326%
Deferred Tax Assets, Operating Loss Carryforwards 42.2M USD +9.77%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 593M USD +3.2%
Depreciation, Depletion and Amortization 5.03M USD +30.7%
Deferred Tax Assets, Net of Valuation Allowance 10.8M USD -5.62%